|Series A, 8/2011 |
OVP Venture Partners
Alexandria Real Estate Equities
ARCH Venture Partners
|Partial Close, 9/2013 ||$1M|
Oncofactor Corporation is a Seattle, WA-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.